291 related articles for article (PubMed ID: 36614082)
21. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Ning L; Li Z; Wei D; Chen H; Yang C
Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
[TBL] [Abstract][Full Text] [Related]
22. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
23. Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Su H; Sun T; Wang H; Shi G; Zhang H; Sun F; Ye D
Oncotarget; 2017 Jan; 8(4):5789-5799. PubMed ID: 27494890
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
[TBL] [Abstract][Full Text] [Related]
25. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.
Wang R; Zheng B; Liu H; Wan X
Cell Cycle; 2020 May; 19(10):1122-1131. PubMed ID: 32286142
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.
Huang T; Wang X; Yang X; Ji J; Wang Q; Yue X; Dong Z
Med Sci Monit; 2018 Oct; 24():7340-7347. PubMed ID: 30317248
[TBL] [Abstract][Full Text] [Related]
29. Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma.
Sun C; Zhou Z; Shi H; Li F; Zhang G
Dis Markers; 2019; 2019():2814058. PubMed ID: 31871500
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
[TBL] [Abstract][Full Text] [Related]
31. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer.
Wang A; Bao Y; Wu Z; Zhao T; Wang D; Shi J; Liu B; Sun S; Yang F; Wang L; Qu L
Cell Death Dis; 2019 Feb; 10(3):154. PubMed ID: 30770799
[TBL] [Abstract][Full Text] [Related]
33. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.
Xiong J; Liu Y; Luo S; Jiang L; Zeng Y; Chen Z; Shi X; Lv B; Tang W
Oncotarget; 2017 Jan; 8(4):6555-6563. PubMed ID: 28030807
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
35. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
36. A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma.
Zhang H; Ye Q; Chen Z; Zhao C; Wu Q; Ding Y; Shao Q; Zhao Y
Dis Markers; 2022; 2022():8928282. PubMed ID: 36438902
[TBL] [Abstract][Full Text] [Related]
37. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of HMGA2 via sponging miR-103a.
Ye ZH; Gui DW; Wang XY; Wang J; Fu JL
J Clin Lab Anal; 2022 Jun; 36(6):e24422. PubMed ID: 35466471
[TBL] [Abstract][Full Text] [Related]
39. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
[TBL] [Abstract][Full Text] [Related]
40. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.
Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J
Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
